<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02001870</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/12/0553</org_study_id>
    <secondary_id>National PHRC 2012</secondary_id>
    <nct_id>NCT02001870</nct_id>
  </id_info>
  <brief_title>Comparison of the Efficiency of Intra-uterine Insemination and in Vitro Fertilization in Women Over 37 Years</brief_title>
  <acronym>AMPAGE</acronym>
  <official_title>Comparison of the Efficiency of Intra-uterine Insemination and in Vitro Fertilization in Women Over 37 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      As age increases the chances for a woman to become pregnant decrease as well spontaneously as
      through assisted reproductive technologies (ART). For the treatment of unexplained
      infertilities two techniques can be used: intra-uterine insemination (IUI) and in vitro
      fertilization (IVF). The aim of the present study is to compare the efficiency in term of
      delivery rate of IUI and IVF in couples in whom the female age is over 37 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      IUI can be used to treat infertility when tubes are normal, with no severe endometriosis and
      enough motile spermatozoa can be inseminated. In these cases IUI are usually performed (4 to
      6 attempts) and IVF only in case of IUI failure. Indeed if the pregnancy rate per attempt is
      higher with IVF, IUI can be performed more frequently (6 times a year vs. 2 for IVF) so that
      the pregnancy rates after one year of treatment are close. When female age is over 37 years,
      some ART centers prefer to perform directly IVF, since chances of pregnancy decreases with
      time. However there is no argument in the literature in favor as well as in disfavor for such
      an attitude. Indeed the delivery rates after one year treatment with IUI or IVF are not known
      in this population. Therefore we propose a multicentric randomized controlled trial comparing
      IUI and IVF in women over 37 with unexplained infertility. Couples will be randomly allocated
      to IUI or IVF during one year. In case of absence of pregnancy after 4 IUI, couples will be
      treated by IVF. ART attempts will be performed according to usual procedures of each center.
      The follow-up will be ended either at the end of the first year of treatment if no pregnancy
      is obtained or at the time of delivery if a pregnancy is obtained. All data of attempts
      (demographics data, type and doses of treatment, adverse effects, outcome, number and health
      state of newborns....) will be recorded.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2014</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Delivery rate.</measure>
    <time_frame>After one year of treatment.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Multiple pregnancy rate</measure>
    <time_frame>After one year of treatment.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of treatment</measure>
    <time_frame>After one year of treatment.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects (hyperstimulation, infections…)</measure>
    <time_frame>After one year of treatment.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Infertilities</condition>
  <arm_group>
    <arm_group_label>In Vitro Fecundation (IVF)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Couples will be treated by In Vitro Fecundation (IVF)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intra Uterine Insemination (IUI)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Couples will be treated by Intra Uterine Insemination (IUI)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>In Vitro Fecundation (IVF)</intervention_name>
    <description>In vivo fertilization will be performed according to the usual procedure of each Assisted Reproductive Technology (ART) center.</description>
    <arm_group_label>In Vitro Fecundation (IVF)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intra Uterine Insemination (IUI)</intervention_name>
    <description>Intra-uterine insemination will be performed according to the usual procedure of each ART center</description>
    <arm_group_label>Intra Uterine Insemination (IUI)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female age between 37 and 42 years at the time of inclusion

          -  Infertility duration ≥ 12 months

          -  Normal tubes

          -  No severe endometriosis

          -  At least 1.5 106 motile spermatozoa to be inseminated

          -  No previous ART attempt

        Exclusion Criteria:

          -  Tubal abnormalities

          -  Severe endometriosis

          -  Less than 1.5 106 motile spermatozoa to be inseminated

          -  Use of frozen sperm

          -  Presence of anti-spermatozoa antibodies
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>37 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean PARINAUD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean PARINAUD, MD</last_name>
    <phone>05 67 77 10 02</phone>
    <phone_ext>33</phone_ext>
    <email>parinaud.j@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Caroline PEYROT, CRA</last_name>
    <phone>05 61 77 84 86</phone>
    <phone_ext>33</phone_ext>
    <email>peyrot.c@chu-toulouse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Toulouse</city>
        <state>Midi-Pyrénnées</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Parinaud, MD</last_name>
      <phone>05 67 77 10 02</phone>
      <phone_ext>33</phone_ext>
      <email>parinaud.j@chu-toulouse.fr</email>
    </contact>
    <contact_backup>
      <last_name>Roger Léandri, MD</last_name>
      <phone>05 67 77 10 02</phone>
      <phone_ext>33</phone_ext>
      <email>leandri.r@chu-toulouse.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Jean PARINAUD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roger LEANDRI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carole FAJAU-PREVOT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florence LESOURD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tiffany COCHET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux Hôpital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clément Jimenez, MD</last_name>
    </contact>
    <investigator>
      <last_name>Clément Jiménez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Brest Hôpital Morvan, service d'AMP</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Merviel</last_name>
      <email>philippe.merviel@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe Merviel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal de Créteil, Service d'AMP</name>
      <address>
        <city>Créteil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Massin</last_name>
      <email>nathalie.massin@chicreteil.fr</email>
    </contact>
    <investigator>
      <last_name>Nathalie Massin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Dijon Laboratoire de biologie de la reproduction</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Institut de Médecine de la Reproduction</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Géraldine Porcu, MD</last_name>
    </contact>
    <investigator>
      <last_name>Géraldine Porcu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier, Médecine de la Reproduction</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>CHU Nantes centre d'AMP</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Barrière, MD</last_name>
    </contact>
    <investigator>
      <last_name>Paul Barrière, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nice centre d'AMP</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>CHI Poissy St-Germain en Laye, centre d'AMP</name>
      <address>
        <city>Poissy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Wainer, MD</last_name>
    </contact>
    <investigator>
      <last_name>Robert Wainer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier des Quatre Villes, Saint-Cloud Service de Médecine de la Reproduction</name>
      <address>
        <city>Saint-Cloud</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joelle Belaisch-Allart</last_name>
      <email>j.belaischallart@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Joelle Belaisch-Allart</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Strasbourg, Centre d'AMP</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Rongieres</last_name>
      <email>catherine.rongieres@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Catherine Rongieres</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2013</study_first_submitted>
  <study_first_submitted_qc>November 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2013</study_first_posted>
  <last_update_submitted>February 2, 2018</last_update_submitted>
  <last_update_submitted_qc>February 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Infertility</keyword>
  <keyword>female age</keyword>
  <keyword>intra-uterine insemination</keyword>
  <keyword>in vitro fecundation</keyword>
  <keyword>assisted reproductive technology center</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

